- Companies
- Artera
Artera Funding, Investors & Competitors
Artera has raised $110M across 3 funding rounds, most recently a $65M Series D in December 2025.
Last Artera funding round
$65M
Series D · Dec 2025
Cumulative funding Artera raised
$110M
across 3 funding rounds
Key investors in Artera
Lead Edge Capital
Jackson Square Ventures
Health Velocity Capital
Summation Health Ventures
Techstars
Right Side Capital Management
Freestyle Capital
Structure Capital
About Artera
Artera is a digital health SaaS provider offering AI-powered virtual agents for patient engagement across voice, text, and web channels in 109 languages. Headquartered in Miami, it serves over 900 healthcare organizations including FQHCs, IDNs, and federal agencies, handling 2 billion annual communications for self-scheduling, intake, billing, and follow-ups. The platform integrates with EHR systems like Epic and Cerner, supporting both staff augmentation and autonomous operations. Founded in 2014 as CareHarmony, Artera drives patient access improvements for 100 million patients yearly.
Founded
2015
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Artera Funding History
Artera has raised a total of $110M across 3 funding rounds.
Artera's first fundraising round was a $100K pre-seed round in March 2016. The most recent completed round was a $65M Series D in December 2025.
Artera funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Dec 2025 | Series D | Lead Edge Capital (lead); Jackson Square Ventures; Health Velocity Capital; Summation Health Ventures; Heritage Medical Systems | $65M | Artera.io develops AI-driven patient communication solutions, combining human and agentic AI to handle scheduling, intake, payments, and follow-ups via text, email, phone, and web. The platform supports over 2 billion annual patient-to-provider communications for more than 1,000 healthcare organizations, including specialty groups, FQHCs, large IDNs, federal agencies like the VA and DoD, and integrates with major EHRs. Artera's AI Flows Agents complete 94% of conversations autonomously, managing 42 million sessions yearly, while recent autonomous AI Agents advance full care journey automation. On December 3, 2025, Artera announced a $65 million growth investment led by Lead Edge Capital, with participation from Jackson Square Ventures, Health Velocity Capital, Heritage Medical Systems, and Summation Health Ventures. The funding aims to accelerate adoption of agentic AI, leveraging Artera's decade of EHR integration, real-world datasets, and compliance (SOC 2 Type 2, HITRUST, HIPAA). The round coincided with Artera reaching $100 million in Contracted Annual Recurring Revenue (CARR) by end-2025, validating its traction amid rising demand for AI in patient access. Artera has engaged over 200 million patients and powers APIs for 50+ digital health vendors. Recognized on Deloitte's 2025 Technology Fast 500 (rank 162 in AI), it continues innovating post-funding, building on prior milestones like Inc. 5000 listings and Medtech Breakthrough awards. Artera positions itself as a first-mover in healthcare AI infrastructure, using standards like Model Context Protocol and emphasizing domain expertise over commoditized tech. The investment sustains its competitive edge against fragmented systems and niche vendors, focusing on scalable, compliant agentic solutions. |
| Nov 2020 | Series C | Lead Edge Capital (lead); Jackson Square Ventures; Health Velocity Capital; Summation Health Ventures; Structure Capital; Freestyle Capital; Martin Ventures | $45M | Artera, formerly known as WELL Health, is a Santa Barbara-based digital health company founded in 2015 that provides an AI-powered patient communications platform for healthcare organizations, enabling streamlined communication via text, phone, and web across the patient journey from scheduling to billing. On November 24, 2020, the company secured a $45 million Series C funding round led by Lead Edge Capital, with participation from Martin Ventures and existing investors Jackson Square Ventures, Health Velocity Capital, Summation Health Ventures, Structure Capital, and Freestyle Capital, bringing total funding raised to $75 million since inception. The investment aimed to support growth amid rising focus on patient experience, reimbursement pressures, and staffing costs, positioning the WELL platform as a core tool for patient engagement with reduced staff needs. Lead Edge Capital, a growth-stage fund with offices in New York and Southern California, highlighted Artera's leadership in patient communications, noting customer enthusiasm for the technology as the backbone of their strategies. The round followed strong performance, including 100% cumulative annual growth mentioned in the announcement. Artera serves healthcare providers, payers, and ACOs, addressing challenges in customer service and business returns through its unified communications solutions. Later developments include a December 2025 $65M growth investment led by Lead Edge Capital with similar investors, at which point Artera reported reaching $100M in Contracted Annual Recurring Revenue (CARR) by year-end, serving over 1,000 customers and engaging 200 million patients with 2 billion annual communications. The company has since expanded into agentic AI agents, Flows Agents, and Co-Pilots, deployed by hundreds of providers post-2024 launch. |
| Mar 2016 | Pre-seed | Techstars (lead); Right Side Capital Management | $100K | - |
Who has invested in Artera?
10 investors have backed Artera across its funding rounds, including Lead Edge Capital, Jackson Square Ventures, Health Velocity Capital, Summation Health Ventures, Techstars and Right Side Capital Management.
Lead investors include Lead Edge Capital and Techstars.
Artera Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Participant | Nov 2020 | ||
| 2 | Lead | Nov 2020 | ||
| 2 | Participant | Nov 2020 | ||
| 2 | Participant | Nov 2020 | ||
| 1 | Participant | Nov 2020 | ||
| 1 | Participant | Nov 2020 | ||
| 1 | Lead | Mar 2016 | ||
| 1 | Participant | Dec 2025 | ||
This data is available for Pro users. Sign up to see all 10 Artera investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialArtera Competitors
Artera competitors include listed companies like Guiyang Longmaster and Medley Inc., and private ones like ConcertAI, Doctolib, Cityblock Health and Hippocratic AI.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $200M | - | $1.9B | 9.5x | ||
| Private | $400M | - | $6.4B | 16.0x | ||
| Private | - | - | $5.7B | - | ||
| Private | - | - | $3.5B | - | ||
| Publicly listed | $44M | $5M | $482M | - | ||
| Publicly listed | $236M | $32M | $459M | 1.8x |
Artera Public Comps
Artera is still privately-owned, but its public comps include CrowdStrike, SAP, Salesforce, ServiceNow, Adobe, Datadog, Moody's, Workday, IQVIA and Veeva.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $4.8B | ($12M) | 51.4x | 44.5x | (19816.2x) | 151.0x | |||
| $42B | $13B | 5.8x | 5.4x | 18.4x | 17.1x | |||
| $42B | $13B | 5.5x | 5.2x | 17.8x | 12.2x | |||
| $13B | $2.6B | 11.1x | 9.6x | 57.2x | 25.0x | |||
| $24B | $9.3B | 4.3x | 3.9x | 10.9x | 8.2x | |||
| $3.4B | ($588K) | 23.6x | 19.4x | (137813.0x) | 77.6x | |||
| $7.7B | $3.8B | 11.2x | 10.6x | 22.5x | 20.1x | |||
| $9.6B | $1.2B | 5.1x | 4.7x | 42.0x | 14.2x | |||
This data is available for Pro users. Sign up to see all Artera competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Artera
| When was Artera founded? | Artera was founded in 2015. |
| Where is Artera headquartered? | Artera is headquartered in Santa Barbara, CA, United States. |
| Is Artera publicly listed? | No, Artera is a private, VC-backed company. |
| How much funding has Artera raised? | Artera has raised $110M across 3 funding rounds. |
| What was Artera's last funding round? | Artera's last funding round was a $65M Series D in December 2025, led by Lead Edge Capital. |
| Who are Artera's investors? | Artera's investors include Jackson Square Ventures, Lead Edge Capital, Health Velocity Capital, Summation Health Ventures, Structure Capital, Freestyle Capital, Techstars, Heritage Medical Systems, Right Side Capital Management and Martin Ventures. |
| Which companies are comparable to Artera? | Companies comparable to Artera include ConcertAI, Doctolib, Cityblock Health, Hippocratic AI, Guiyang Longmaster and Medley Inc.. |
See companies similar to Artera
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




